Interferon-gamma induces downregulation of Tangier disease gene (ATP-binding-cassette transporter 1) in macrophage-derived foam cells.
暂无分享,去创建一个
[1] A. Vaughan,et al. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. , 1999, The Journal of clinical investigation.
[2] Y. Takahashi,et al. Cholesterol efflux to apolipoprotein AI involves endocytosis and resecretion in a calcium-dependent pathway. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[3] M. Freeman. Effluxed lipids: Tangier Island's latest export. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[4] T. Langmann,et al. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease , 1999, Nature Genetics.
[5] C. Sensen,et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency , 1999, Nature Genetics.
[6] S. Young,et al. The ABCs of cholesterol efflux , 1999, Nature Genetics.
[7] J. Piette,et al. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1 , 1999, Nature Genetics.
[8] K. Williams,et al. Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.
[9] C. Argmann,et al. Uptake of type IV hypertriglyceridemic VLDL by cultured macrophages is enhanced by interferon-gamma. , 1999, Journal of lipid research.
[10] D. Williams,et al. Induction of cellular cholesterol efflux to lipid-free apolipoprotein A-I by cAMP. , 1999, Biochimica et biophysica acta.
[11] T. Langmann,et al. Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages. , 1999, Biochemical and biophysical research communications.
[12] M. Connelly,et al. Scavenger receptor BI (SR-BI) mediates free cholesterol flux independently of HDL tethering to the cell surface. , 1999, Journal of lipid research.
[13] A. Chamberland,et al. Expression of gamma-IFN responsive genes in scavenger receptor over-expressing monocytes is associated with xanthomatosis. , 1998, Atherosclerosis.
[14] G. Hansson. Cell-mediated immunity in atherosclerosis , 1997, Current opinion in lipidology.
[15] A Daugherty,et al. The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice. , 1997, The Journal of clinical investigation.
[16] A J Mendez,et al. Cholesterol efflux mediated by apolipoproteins is an active cellular process distinct from efflux mediated by passive diffusion. , 1997, Journal of lipid research.
[17] Yong Ji,et al. Scavenger Receptor BI Promotes High Density Lipoprotein-mediated Cellular Cholesterol Efflux* , 1997, The Journal of Biological Chemistry.
[18] A. Groen,et al. The role of mdr2 P‐glycoprotein in hepatobiliary lipid transport , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[19] S. Yokoyama,et al. Apolipoprotein-mediated removal of cellular cholesterol and phospholipids. , 1996, Journal of lipid research.
[20] A. vonEckardstein. Cholesterol efflux from macrophages and other cells. , 1996 .
[21] M. Luciani,et al. The ATP binding cassette transporter ABC1, is required for the engulfment of corpses generated by apoptotic cell death. , 1996, The EMBO journal.
[22] Fei Wang,et al. Regulation of the balance of cytokine production and the signal transducer and activator of transcription (STAT) transcription factor activity by cytokines and inflammatory synovial fluids , 1995, The Journal of experimental medicine.
[23] M. Bruzelius,et al. Expression of the macrophage scavenger receptor in atheroma. Relationship to immune activation and the T-cell cytokine interferon-gamma. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[24] G. Francis,et al. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease. , 1995, The Journal of clinical investigation.
[25] M. Soares,et al. Construction and characterization of a normalized cDNA library. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[26] A. Tall. An overview of reverse cholesterol transport. , 1994, European heart journal.
[27] F. Denizot,et al. Cloning of two novel ABC transporters mapping on human chromosome 9. , 1994, Genomics.
[28] J. Slotte,et al. Cyclic AMP stimulates efflux of intracellular sterol from cholesterol-loaded cells. , 1993, The Journal of biological chemistry.
[29] S. Yokoyama,et al. Cholesterol is poorly available for free apolipoprotein-mediated cellular lipid efflux from smooth muscle cells. , 1993, Biochemistry.
[30] P. Quesenberry,et al. Regulation of macrophage alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein by lipopolysaccharide and interferon-gamma. , 1993, The Journal of clinical investigation.
[31] P. Libby,et al. An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.
[32] P. Cresswell,et al. Cytokines increase transporter in antigen processing-1 expression more rapidly than HLA class I expression in endothelial cells. , 1992, Journal of immunology.
[33] W. J. Johnson,et al. Apolipoproteins, membrane cholesterol domains, and the regulation of cholesterol efflux. , 1992, Journal of lipid research.
[34] G. Hansson,et al. Interferon-gamma inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages. , 1992, The Journal of clinical investigation.
[35] S. Yokoyama,et al. Interaction of free apolipoproteins with macrophages. Formation of high density lipoprotein-like lipoproteins and reduction of cellular cholesterol. , 1991, The Journal of biological chemistry.
[36] S. Beck,et al. Sequences encoded in the class II region of the MHC related to the 'ABC' superfamily of transporters , 1990, Nature.
[37] U. Querfeld,et al. Effects of cytokines on the production of lipoprotein lipase in cultured human macrophages. , 1990, Journal of lipid research.
[38] G. Hansson,et al. Detection of activated T lymphocytes in the human atherosclerotic plaque. , 1989, The American journal of pathology.
[39] M. Brown,et al. A receptor-mediated pathway for cholesterol homeostasis. , 1986, Science.
[40] G. Gabbiani,et al. Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis. , 1985, The Journal of clinical investigation.
[41] L. Avioli,et al. Tangier Disease: Combined Clinical Staff Conference at the National Institutes of Health , 1961 .
[42] W. J. Dyer,et al. A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.
[43] S. Zuckerman,et al. Regulation of cholesterol distribution in macrophage-derived foam cells by interferon-gamma. , 2000, Journal of lipid research.
[44] P. Libby,et al. Regulation of smooth muscle cell scavenger receptor expression in vivo by atherogenic diets and in vitro by cytokines. , 1995, The Journal of clinical investigation.
[45] M. Brown,et al. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. , 1983, Annual review of biochemistry.